Transcatheter Aortic Valve Implantation

Current and Future Developments
Herausgeber: Serruys, Patrick W; Leon, Martin B; Webb, John G; Onuma, Yoshinobu; Makkar, Raj; Grube, Eberhard; Eltchaninoff, Helene; Cribier, Alain

• Gebundenes Buch

Produktbeschreibung

Written by pioneers in the field of interventional cardiology, this new edition provides readers with the information and expert guidance needed to perform safe and effective transcatheter aortic valve implantation/replacement (TAVI/TAVR).

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: CRC Press
• 2nd edition
• Seitenzahl: 374
• Erscheinungstermin: 10. September 2024
• Englisch
• Abmessung: 280mm x 210mm
• Gewicht: 453g
• ISBN-13: 9781032471471
• ISBN-10: 1032471476
• Artikelnr.: 70147498

Autorenporträt

Patrick W. Serruys, MD, PhD, eFESC, FACC is an established professor of Interventional medicine and innovation at NUI Galway, and senior consultant with CORRIB Research Centre for Advanced Imaging and Core Laboratory and College of Medicine, Nursing and Health Sciences, University of Galway, Ireland. Alain Cribier, MD, FACC, FESC was formerly emeritus professor of medicine and past-head of the Department of Cardiology at University Hospital Charles Nicolle, Rouen, France. Helene Eltchaninoff, MD is professor and head of department of Cardiology, Centre hospitalier universitaire de Rouen, Rouen, France. Eberhard Grube, MD, MSCAI is professor of medicine and chief of the department of Cardiology and Angiology,University Hospital Bonn, Germany and Consulting Professor, Division of Cardiovascular Medicine, Stanford University School of Medicine, California, USA. Raj Makkar, MD is associated with the Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Yoshinobu Onuma, MD, PhD is professor in Interventional Cardiology and medical director, CORRIB Core Laboratory, University of Galway, Ireland. John G Webb, MD, FRCPC is McLeod professor of Heart Valve Intervention, University of British Columbia, Vancouver, BC, Canada. Martin B Leon, MD is the director of the Center for Interventional Vascular Therapy, New York-Presbyterian/Columbia University Irving Medical Center, New York, NY, USA. Associate Editors: TsungYing Tsai, PhD is associated with the CORRIB Core Laboratory, University of Galway, Ireland. Pruthvi C Revaiah, MD, DM is associated with the CORRIB Research Center for Advanced Imaging, University of Galway, Ireland.

Inhaltsangabe

Preface.
List of contributors.
1.1. Transcatheter Aortic Valve Implantation over the first 20 years: from
an idea (balloon expandable valves) to human implementation. 1.2. Give the
floor to the patients: the first transfemoral case in the world. 2.1.
Normal anatomy and imaging. 2.2. Pathologic anatomy and imaging for
Transcatheter Aortic Valve Implantation. 2.3. Post- Transcatheter Aortic
Valve Implantation bioprosthetic valve degeneration and imaging modalities
. 3. Risk scores (risk stratification). 4. Fundamentals of patient and
device selection. 5. Staging of cardiac damage for patients with aortic
stenosis. 6. Low flow-low-gradient Transcatheter Aortic Valve Replacement.
7. Transcatheter Aortic Valve Implantation Access: from transfemoral to
alternate access and closure strategies. 8.1. Imaging guidance in
Transcatheter Aortic Valve Implantation (pre- and intra-procedural
imaging): echocardiography. 8.2. Imaging guidance in Transcatheter Aortic
Valve Implantation: multi-slice Computed Tomography. 8.3. Imaging guidance
in Transcatheter Aortic Valve Implantation: Cardiac Magnetic Resonance.
8.4. Imaging guidance in Transcatheter Aortic Valve Implantation (pre- and
intra-procedural imaging): angiography. 9. Transcatheter Aortic Valve
Implantation devices, landscape, and patient-tailored device selection.
10. The minimalist approach to Transcatheter Aortic Valve Implantation.
11. Bioprosthetic aortic valve thrombosis in the era of Transcatheter
Aortic Valve Replacement: pathophysiology, diagnosis, incidence, clinical
implications, and management. 12. Transcatheter Aortic Valve Replacement in
the bicuspid aortic valve. 13. Transcatheter Aortic Valve Replacement for
severe aortic regurgitation. 14. Transcatheter Aortic Valve Implantation in
Surgical Aortic Valve Replacement. 15. Surgical explantation after
Transcatheter Aortic Valve Replacement failure. 16. Transcatheter Aortic
Valve Implantation in Transcatheter Aortic Valve Implantation. 17.
Sophisticated hemodynamic assessment. 18. Evaluation of coronary artery
disease, anatomical and physiological in patients with aortic stenosis.
19. Coronary obstruction following Transcatheter Aortic Valve Implantation
. 20. Coronary and commissural alignment of the novel Transcatheter Aortic
Valve Implantation devices. 21. Antithrombotic therapy after Transcatheter
Aortic Valve Implantation - Antonio Greco and Davide Capodanno. 22.
Embolic protection devices and Transcatheter Aortic Valve Replacement.
23.1. Complication: conduction disturbances. 23.2. Complication: stroke
prevention and management. 23.3. Complication: Vascular and annular injury
. 23.4. Complication: coronary complications (prevention and management).
23.5. Complication: management of concomitant coronary artery disease.
23.6. Complication: miscellaneous - infective endocarditis and acute renal
dysfunction. 23.7. Complication: transcatheter valve embolization and
migration. 24. Infective endocarditis and evolving transcatheter treatment
options. 25. Virtual, mixed, and augmented reality in the aortic space.
26. The role of percutaneous balloon aortic valvuloplasty (before, during,
and after). 27. The ongoing and missing Transcatheter Aortic Valve
Implantation trials (a search in clinical trials.gov). 28. Post-mortem and
surgically removed valve pathology. 29.1. Worldwide geographic
dissemination of Transcatheter Aortic Valve Implantation: Europe. 29.2.
Worldwide geographic dissemination of Transcatheter Aortic Valve
Implantation: USA. 29.3. Worldwide geographic dissemination of
Transcatheter Aortic Valve Replacement: Latin America. 29.4. Worldwide
geographic dissemination of Transcatheter Aortic Valve Implantation: China
. 29.5. Worldwide geographic dissemination of Transcatheter Aortic Valve
Replacement: India. 29.6. Worldwide geographic dissemination of
Transcatheter Aortic Valve Implantation: Japan. 29.7. Worldwide geographic
dissemination of Transcatheter Aortic Valve Implantation: Taiwan and
southeast Asia. 30. Novel Transcatheter Aortic Valve Implantation devices
from emerging markets in China. 31. Novel Transcatheter Aortic Valve
Implantation systems from India. 32. Prediction of the surgeons for the
next decade (how the aortic valve will be treated). 33. The future of
pharmacological prevention of aortic valve stenosis. 34. The future of
Transcatheter Aortic Valve Replacement.
Index.